Pharmaceutical Executive Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
Mar 24, 2025
Peter Ax, Founder & CEO of UpScriptHealth, dives into how tariffs affect both branded and generic medications. He highlights potential shifts in U.S. manufacturing and strategic supply chain adjustments due to these tariffs. The discussion also emphasizes the role of digital health platforms in reducing costs and improving patient care through telehealth. Ax shares insights on forging partnerships to enhance medication accessibility and the need for innovation to rebuild trust between pharma and patients.
AI Snips
Chapters
Transcript
Episode notes
Tariffs Impact Pharma Markets Differently
- Tariffs impact pharmaceutical branded and generic markets differently, affecting raw material costs and labor.
- Short term burden falls on pharma companies, with long-term effects passing on to consumers.
Tariffs Prompt Supply Chain Strategy
- Tariffs push pharma companies to rethink and possibly relocate supply chains, including manufacturing.
- Boardrooms face strategic decisions on onshoring and asset redeployment due to tariff risks.
Use Digital Platforms To Cut Costs
- Digital health platforms can cut healthcare costs and friction to offset tariff-driven increases.
- Simplify insurance processes and speed therapy access to improve patient affordability.